Thumbnail
Access Restriction
Subscribed

Author Houghton, P. W. ♦ Mortensen, N. J. ♦ Allan, A. ♦ Williamson, R. C. ♦ Davies, J. D.
Source British Medical Journal (The BMJ)
Content type Text
Publisher British Medical Journal Publishing Group
File Format HTM / HTML
Language English
Abstract Thirty five patients with early gastric cancer have been treated at the Bristol Royal Infirmary since 1965. The number of cases diagnosed has doubled in the last 10 years. Epigastric pain (74%), loss of weight (63%), and gastrointestinal bleeding (43%) were the most common presenting symptoms, with a median length of history of 12 months (range five days to 72 months). Life table survival curves showed a crude five year survival of 71% (age adjusted 92%) and a crude 10 year survival of 63% (age adjusted 85%). Sixteen patients have been followed up clinically, endoscopically, and by scintigraphy with technetium-99m p-butyl iminodiacetic acid to assess the risk of recurrent disease. Of seven patients with pronounced bile reflux, two had moderate dysplasia of the gastric remnant, and one patient was found to have developed a metachronous tumour nine years after surgery. Partial resection seems to be the best choice of treatment for early gastric cancer, giving good functional results. Consideration should, however, be given to Roux en Y diversion, and long term surveillance of the gastric remnant is recommended.
Description Citation Reference: British Medical Journal (Clinical Research Ed.)
ISSN 02670623
Age Range 18 to 22 years ♦ above 22 year
Educational Use Research
Learning Resource Type Article
Publisher Date 1985-08-03
e-ISSN 14685833
Journal British Medical Journal (The BMJ)
Volume Number 291
Issue Number 6491
Page Count 4
Starting Page 305
Ending Page 308


Open content in new tab

   Open content in new tab
Source: British Medical Journal (The BMJ)